Refractory congestive heart failure after ribavirin in infants with heart disease and respiratory syncytial virus.

J. T. Martin, John Dale Kugler, Carl Herbert Gumbiner, J. C. Brown, K. R. Murphy, John Louis Colombo, B. M. McManus

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Although treatment with ribavirin has been known to be associated with a decreased mortality in infants with congenital heart disease (CHD) who have respiratory syncytial virus (RSV), few data are available regarding morbidity. We reviewed records of 10 consecutively hospitalized infants with CHD during a recent RSV epidemic. Despite the presence of left-to-right shunt in each patient, symptoms of RSV were respiratory at presentation. After ribavirin, decreased respiratory symptoms were found in 8 infants but in 2 assisted ventilation were required 1 and 3 days after admission. Congestive heart failure worsened in 8 patients, 6 of whom had improved respiratory status after ribavirin. Of the 8 patients with worse CHF (pulmonary edema), 3 responded to medical management but 5 were refractory and 4 required surgical repair of CHD. One patient died of pulmonary hemorrhage. Medically refractory CHF may develop in infants with CHD who become infected with RSV and are treated with ribavirin. Further studies are needed to determine whether the pulmonary edema is caused by RSV, ribavirin, or combination of effects on pulmonary capillary function or some other unrecognized mechanism.

Original languageEnglish (US)
Pages (from-to)23-26
Number of pages4
JournalThe Nebraska medical journal
Volume75
Issue number2
StatePublished - Feb 1990

Fingerprint

Respiratory Syncytial Viruses
Ribavirin
Heart Diseases
Heart Failure
Pulmonary Edema
Lung
Infant Mortality
Ventilation
Hemorrhage
Morbidity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Refractory congestive heart failure after ribavirin in infants with heart disease and respiratory syncytial virus. / Martin, J. T.; Kugler, John Dale; Gumbiner, Carl Herbert; Brown, J. C.; Murphy, K. R.; Colombo, John Louis; McManus, B. M.

In: The Nebraska medical journal, Vol. 75, No. 2, 02.1990, p. 23-26.

Research output: Contribution to journalArticle

@article{13c7986c894e45bcabd59975766fb7d7,
title = "Refractory congestive heart failure after ribavirin in infants with heart disease and respiratory syncytial virus.",
abstract = "Although treatment with ribavirin has been known to be associated with a decreased mortality in infants with congenital heart disease (CHD) who have respiratory syncytial virus (RSV), few data are available regarding morbidity. We reviewed records of 10 consecutively hospitalized infants with CHD during a recent RSV epidemic. Despite the presence of left-to-right shunt in each patient, symptoms of RSV were respiratory at presentation. After ribavirin, decreased respiratory symptoms were found in 8 infants but in 2 assisted ventilation were required 1 and 3 days after admission. Congestive heart failure worsened in 8 patients, 6 of whom had improved respiratory status after ribavirin. Of the 8 patients with worse CHF (pulmonary edema), 3 responded to medical management but 5 were refractory and 4 required surgical repair of CHD. One patient died of pulmonary hemorrhage. Medically refractory CHF may develop in infants with CHD who become infected with RSV and are treated with ribavirin. Further studies are needed to determine whether the pulmonary edema is caused by RSV, ribavirin, or combination of effects on pulmonary capillary function or some other unrecognized mechanism.",
author = "Martin, {J. T.} and Kugler, {John Dale} and Gumbiner, {Carl Herbert} and Brown, {J. C.} and Murphy, {K. R.} and Colombo, {John Louis} and McManus, {B. M.}",
year = "1990",
month = "2",
language = "English (US)",
volume = "75",
pages = "23--26",
journal = "The Nebraska medical journal",
issn = "0091-6730",
publisher = "Nebraska State Medical Association",
number = "2",

}

TY - JOUR

T1 - Refractory congestive heart failure after ribavirin in infants with heart disease and respiratory syncytial virus.

AU - Martin, J. T.

AU - Kugler, John Dale

AU - Gumbiner, Carl Herbert

AU - Brown, J. C.

AU - Murphy, K. R.

AU - Colombo, John Louis

AU - McManus, B. M.

PY - 1990/2

Y1 - 1990/2

N2 - Although treatment with ribavirin has been known to be associated with a decreased mortality in infants with congenital heart disease (CHD) who have respiratory syncytial virus (RSV), few data are available regarding morbidity. We reviewed records of 10 consecutively hospitalized infants with CHD during a recent RSV epidemic. Despite the presence of left-to-right shunt in each patient, symptoms of RSV were respiratory at presentation. After ribavirin, decreased respiratory symptoms were found in 8 infants but in 2 assisted ventilation were required 1 and 3 days after admission. Congestive heart failure worsened in 8 patients, 6 of whom had improved respiratory status after ribavirin. Of the 8 patients with worse CHF (pulmonary edema), 3 responded to medical management but 5 were refractory and 4 required surgical repair of CHD. One patient died of pulmonary hemorrhage. Medically refractory CHF may develop in infants with CHD who become infected with RSV and are treated with ribavirin. Further studies are needed to determine whether the pulmonary edema is caused by RSV, ribavirin, or combination of effects on pulmonary capillary function or some other unrecognized mechanism.

AB - Although treatment with ribavirin has been known to be associated with a decreased mortality in infants with congenital heart disease (CHD) who have respiratory syncytial virus (RSV), few data are available regarding morbidity. We reviewed records of 10 consecutively hospitalized infants with CHD during a recent RSV epidemic. Despite the presence of left-to-right shunt in each patient, symptoms of RSV were respiratory at presentation. After ribavirin, decreased respiratory symptoms were found in 8 infants but in 2 assisted ventilation were required 1 and 3 days after admission. Congestive heart failure worsened in 8 patients, 6 of whom had improved respiratory status after ribavirin. Of the 8 patients with worse CHF (pulmonary edema), 3 responded to medical management but 5 were refractory and 4 required surgical repair of CHD. One patient died of pulmonary hemorrhage. Medically refractory CHF may develop in infants with CHD who become infected with RSV and are treated with ribavirin. Further studies are needed to determine whether the pulmonary edema is caused by RSV, ribavirin, or combination of effects on pulmonary capillary function or some other unrecognized mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0025379739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025379739&partnerID=8YFLogxK

M3 - Article

C2 - 2308658

AN - SCOPUS:0025379739

VL - 75

SP - 23

EP - 26

JO - The Nebraska medical journal

JF - The Nebraska medical journal

SN - 0091-6730

IS - 2

ER -